SCHEMBL3041015

SCHEMBL3041015

Nc1cc2[nH]cnc2cc1Cl

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.70
KDM4E B2RXH2 4/20 0.70
ALDH1A1 P00352 3/20 0.70
BLM P54132 2/20 0.70
APEX1 P27695 1/20 0.70
RECQL P46063 1/20 0.70
TDP1 Q9NUW8 1/20 0.70
PRKCI P41743 1/20 0.50
RAD52 P43351 1/20 0.48
GAA P10253 1/20 0.42
CASP6 P55212 2/20 0.42
CHRNB2 P17787 1/20 0.39
CHRNA4 P43681 1/20 0.39
QPCT Q16769 1/20 0.38
QPCTL Q9NXS2 1/20 0.38
MMP12 P39900 1/20 0.38
CYP3A4 P08684 1/20 0.37
NAMPT P43490 1/20 0.37
XDH P47989 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27459919 0.92 MAPT (0.70) MAPTKDM4EALDH1A1BLMAPEX1
SCHEMBL4370465 0.83 MAPT (1.00) MAPTKDM4EALDH1A1BLMAPEX1
SCHEMBL352396 0.83 MAPT (0.70) MAPTKDM4EALDH1A1BLMAPEX1
Hydrochloric Acid SCHEMBL5651319 0.81 MAPT (0.95) MAPTKDM4EALDH1A1BLMAPEX1
Hydrochloric Acid SCHEMBL22748994 0.81 MAPT (0.68) MAPTKDM4EALDH1A1BLMAPEX1
SCHEMBL23124230 0.76 MAPT (0.61) MAPTKDM4EALDH1A1BLMAPEX1
SCHEMBL31156360 0.76 MAPT (1.00) MAPTKDM4EALDH1A1BLMAPEX1
SCHEMBL1839055 0.76 MAPT (0.70) MAPTKDM4EALDH1A1BLMAPEX1
SCHEMBL10884689 0.76 MAPT (0.70) MAPTKDM4EALDH1A1BLMAPEX1
SCHEMBL3891255 0.76 MAPT (0.61) MAPTKDM4EALDH1A1BLMAPEX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100216801-A1 THIAZOLONES FOR USE AS PI3 KINASE INHIBITORS SMITHKLINE BEECHAM CORPORATION 2010-08-26 US disclosed
US-20090203692-A1 NOVEL CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION 2009-08-13 US disclosed
EP-1993538-A2 THIAZOLONES FOR USE AS PI3 KINASE INHIBITORS SmithKline Beecham Corporation (US) 2008-11-26 EP disclosed
EP-1885362-A2 NOVEL CHEMICAL COMPOUNDS Smithkline Beecham Corporation (US) 2008-02-13 EP disclosed
WO-2007103758-A2 THIAZOLONES FOR USE AS PI3 KINASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2007-09-13 WO disclosed
WO-2006127458-A2 NOVEL CHEMICAL COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2006-11-30 WO disclosed
CN-1146539-C Process for preparing sparingly soluble aromatic amines �������⻯ѧƷ�ع����޹�˾ 2004-04-21 CN disclosed
CN-1288461-A Process for preparing sparingly soluble aromatic amines CIBA SC HOLDING AG (CH) 2001-03-21 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100216801-A1 THIAZOLONES FOR USE AS PI3 KINASE INHIBITORS PIK3CA, BTK, PI4KA MAPT 2228/4885KDM4E 3686/4885ALDH1A1 1198/4885
US-20090203692-A1 NOVEL CHEMICAL COMPOUNDS HIPK3, HIPK1, HIPK4 MAPT 1880/4885KDM4E 2665/4885ALDH1A1 4089/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.